NIMR - Mbeya Medical Research Center
Who are we?
Units and Departments
Internal: Stores MS
Internal: Asset MS
Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial